Patents by Inventor Nathan Robert AUGSPURGER
Nathan Robert AUGSPURGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12478080Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: GrantFiled: December 22, 2020Date of Patent: November 25, 2025Assignee: MICROBIAL DISCOVERY GROUP, LLCInventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
-
Patent number: 12390497Abstract: The invention relates to compositions comprising microbial strains for use in inhibiting viruses, and methods therefor. More particularly, the invention relates to compositions of isolated Bacillus strains selected from the group consisting of isolated Bacillus strains 300, 86, 101, 235, 102, 177, A12, 54, 681, 721, strains having all of the identifying characteristics of these strains, and combinations thereof, and methods for use of these strains for virus inhibition.Type: GrantFiled: March 19, 2020Date of Patent: August 19, 2025Assignees: MICROBIAL DISCOVERY GROUP, LLC, UNITED ANIMAL HEALTH, INC.Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Kyle Leistikow
-
Patent number: 11998576Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.Type: GrantFiled: August 16, 2021Date of Patent: June 4, 2024Assignees: MICROBIAL DISCOVERY GROUP, LLC, UNITED ANIMAL HEALTH, INC.Inventors: Michael R. King, Sona Son, Kyle Leistikow, Nathan Robert Augspurger
-
Publication number: 20220241352Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.Type: ApplicationFiled: August 16, 2021Publication date: August 4, 2022Inventors: Michael R. KING, Sona SON, Kyle LEISTIKOW, Nathan Robert AUGSPURGER
-
Publication number: 20220143109Abstract: The invention relates to compositions comprising microbial strains for use in inhibiting viruses, and methods therefor. More particularly, the invention relates to compositions of isolated Bacillus strains selected from the group consisting of isolated Bacillus strains 300, 86, 101, 235, 102, 177, A12, 54, 681, 721, strains having all of the identifying characteristics of these strains, and combinations thereof, and methods for use of these strains for virus inhibition.Type: ApplicationFiled: March 19, 2020Publication date: May 12, 2022Inventors: Michael R. KING, Sona SON, Nathan Robert AUGSPURGER, Joel Dean SPENCER, Kyle LEISTIKOW
-
Publication number: 20210360945Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: ApplicationFiled: December 22, 2020Publication date: November 25, 2021Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
-
Patent number: 11110134Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.Type: GrantFiled: June 27, 2019Date of Patent: September 7, 2021Assignees: Microbial Discovery Group, LLC, United Animal Health, Inc.Inventors: Michael R. King, Sona Son, Kyle Leistikow, Nathan Robert Augspurger
-
Patent number: 10905135Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: GrantFiled: October 3, 2019Date of Patent: February 2, 2021Assignee: Microbial Discovery Group, LLCInventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
-
Publication number: 20200029592Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: ApplicationFiled: October 3, 2019Publication date: January 30, 2020Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
-
Publication number: 20200016217Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.Type: ApplicationFiled: June 27, 2019Publication date: January 16, 2020Inventors: Michael R. King, Sona SON, Kyle Leistikow, Nathan Robert Augspurger
-
Publication number: 20200015497Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: ApplicationFiled: June 27, 2019Publication date: January 16, 2020Inventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
-
Patent number: 10357046Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: GrantFiled: May 13, 2015Date of Patent: July 23, 2019Assignee: Microbial Discovery Group, LLCInventors: Michael R. King, Sona Son, Nathan Robert Augspurger, Joel Dean Spencer, Amy Lange, Michael D. Engelhardt
-
Patent number: 10335440Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.Type: GrantFiled: February 28, 2017Date of Patent: July 2, 2019Assignees: Microbial Discovery Group, LLC, United Animal Health, Inc.Inventors: Michael R. King, Sona Son, Kyle Leistikow, Nathan Robert Augspurger
-
Publication number: 20170246224Abstract: The invention relates to direct-fed microbials for use in E. coli inhibition in animals. More particularly, the invention relates to isolated Bacillus strains 101, 235, 77, 177, and 102 and strains having all of the identifying characteristics of these strains, for a use comprising the above-mentioned use. The invention can also be used for treatment of plants and in food processing.Type: ApplicationFiled: February 28, 2017Publication date: August 31, 2017Inventors: Michael R. KING, Sona SON, Kyle LEISTIKOW, Nathan Robert AUGSPURGER
-
Publication number: 20170079308Abstract: The present invention is directed to direct-fed microbials for use in improving the performance of an animal, improving the health of an animal, improving the environment of an animal, and combinations thereof. More particularly, the invention relates to isolated Bacillus strains 86 and 300, and strains having all of the identifying characteristics of these strains, for uses comprising the above-mentioned uses.Type: ApplicationFiled: May 13, 2015Publication date: March 23, 2017Applicant: MICROBIAL DISCOVERY GROUP, LLCInventors: Michael R. KING, Sona SON, Nathan Robert AUGSPURGER, Joel Dean SPENCER, Amy LANGE, Michael D. ENGLEHARDT